Great Lakes Advisors LLC Makes New Investment in Danaher Corporation $DHR

Great Lakes Advisors LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 225,221 shares of the conglomerate’s stock, valued at approximately $162,171,000. Danaher comprises about 1.2% of Great Lakes Advisors LLC’s portfolio, making the stock its 17th largest position.

Several other hedge funds have also recently modified their holdings of the stock. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Danaher by 303.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after buying an additional 186,584 shares during the last quarter. Legal & General Group Plc grew its holdings in shares of Danaher by 1.0% during the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after buying an additional 43,169 shares during the last quarter. Advisors Capital Management LLC increased its position in shares of Danaher by 14.0% in the 4th quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock valued at $12,555,000 after acquiring an additional 6,720 shares during the period. Handelsbanken Fonder AB increased its position in shares of Danaher by 10.9% in the 2nd quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock valued at $55,091,000 after acquiring an additional 28,425 shares during the period. Finally, Swiss Life Asset Management Ltd raised its stake in Danaher by 12.1% in the 4th quarter. Swiss Life Asset Management Ltd now owns 115,335 shares of the conglomerate’s stock worth $26,402,000 after acquiring an additional 12,416 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. UBS Group lowered their price target on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Guggenheim reduced their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Wells Fargo & Company decreased their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. Stifel Nicolaus dropped their target price on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Finally, Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Stock Up 6.2%

Shares of DHR stock opened at $211.92 on Thursday. The stock has a 50 day moving average of $194.30 and a 200 day moving average of $192.44. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market cap of $148.98 billion, a P/E ratio of 37.64, a P/E/G ratio of 2.49 and a beta of 0.78. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.77 EPS. As a group, sell-side analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.